Literature DB >> 12084255

Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia.

T A Boon1, G E Van Venrooij, M D Eckhardt.   

Abstract

This article reviews the recent literature on men with diabetes mellitus (DM) and concomitant lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Diabetes is reported to be associated with greater BPH symptom severity. Men with non-insulin-dependent diabetes had the highest median annual prostate growth rate compared with those who had other metabolic disease. Urodynamic evaluations in the reviewed studies were absent. Extensive diagnostic evaluations with urodynamics in our outpatient department revealed that patients with LUTS suggestive of BPH and with concomitant DM hardly differed from those without DM.

Entities:  

Mesh:

Year:  2001        PMID: 12084255     DOI: 10.1007/s11934-001-0067-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  9 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

Review 2.  The Abrams-Griffiths nomogram.

Authors:  C S Lim; P Abrams
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  Lack of association between cystopathy and progression of diabetic nephropathy in insulin-dependent diabetes mellitus.

Authors:  O Torffvit; C D Agardh; A Mattiasson
Journal:  Scand J Urol Nephrol       Date:  1997-08

Review 4.  Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple.

Authors:  W Schäfer
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease.

Authors:  V Menéndez; F Cofán; R Talbot-Wright; M J Ricart; R Gutiérrez; P Carretero
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

6.  Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Authors:  M C Michel; L Mehlburger; H Schumacher; H U Bressel; M Goepel
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

7.  Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

Authors:  J Hammarsten; B Högstedt
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

8.  Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response.

Authors:  T Ueda; N Yoshimura; O Yoshida
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

9.  Cystometric evaluation of bladder dysfunction in elderly diabetic patients.

Authors:  P Starer; L Libow
Journal:  Arch Intern Med       Date:  1990-04
  9 in total
  14 in total

1.  The comparison of GLUT-4 and nNOS expression in diabetic and non-diabetic patients with BPH/LUTS.

Authors:  Alper Otunctemur; Huseyin Besiroglu; Murat Dursun; Levent Ozcan; Emre Can Polat; Adnan Somay; Nurver Ozbay; Kutan Ozer; Emin Ozbek
Journal:  Int Urol Nephrol       Date:  2015-04-03       Impact factor: 2.370

Review 2.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

3.  Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.

Authors:  Aruna V Sarma; Jennifer L St Sauver; John M Hollingsworth; Debra J Jacobson; Michaela E McGree; Rodney L Dunn; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2011-11-23       Impact factor: 2.649

4.  Validation of supra-pubic ultrasonography for preoperative prostate volume measurement in sub-Saharan Africa.

Authors:  Kalisya Malemo; Moses Galukande; Michael Hawkes; Sam Bugeza; K Nyavandu; Sam Kaggwa
Journal:  Int Urol Nephrol       Date:  2010-09-17       Impact factor: 2.370

5.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

Review 6.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

Review 7.  Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.

Authors:  Benjamin N Breyer; Aruna V Sarma
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

8.  Roles of urology as assessed by an analysis of inpatients referred to urology.

Authors:  Geun Jae Lee; Min Seok Kim; Sung Min Song; Joon Rho; Won Jin Cho
Journal:  Korean J Urol       Date:  2012-09-19

9.  Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  BMC Cancer       Date:  2013-01-04       Impact factor: 4.430

10.  Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?

Authors:  Ioannis Protopsaltis; Achilles Ploumidis; Theodoros N Sergentanis; Padelis Constantoulakis; Kostantinos Tzirogiannis; Chrysoula Kyprianidou; Athanasia K Papazafiropoulou; Andreas Melidonis; Dimitrios Delakas
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.